Olivier Loeillot insider trades
Open-market stock purchases and sales by Olivier Loeillot, Chief Executive Officer at Repligen Corp, from SEC Form 4 filings since Oct 2, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 5, 2026 | RGEN Repligen Corp | Sold | $238K |
| Oct 5, 2026 | RGEN Repligen Corp | Sold | $798K |
| Oct 5, 2026 | RGEN Repligen Corp | Bought (not open market) | $651K |
| Oct 5, 2026 | RGEN Repligen Corp | Bought (not open market) | — |
| Oct 2, 2026 | RGEN Repligen Corp | Sold (not open market) | $227K |
| Sep 24, 2026 | RGEN Repligen Corp | Sold | $1.6M |
| Sep 24, 2026 | RGEN Repligen Corp | Sold | $863K |
| Sep 24, 2026 | RGEN Repligen Corp | Bought (not open market) | $1.3M |
| Sep 24, 2026 | RGEN Repligen Corp | Bought (not open market) | $706K |
| Sep 24, 2026 | RGEN Repligen Corp | Bought (not open market) | — |
| Sep 24, 2026 | RGEN Repligen Corp | Bought (not open market) | — |
| Sep 21, 2026 | RGEN Repligen Corp | Sold | $977K |
| Sep 21, 2026 | RGEN Repligen Corp | Bought (not open market) | $769K |
| Sep 21, 2026 | RGEN Repligen Corp | Bought (not open market) | — |
| Sep 4, 2026 | RGEN Repligen Corp | Sold | $504K |
| Sep 3, 2026 | RGEN Repligen Corp | Sold (not open market) | $482K |
| Aug 20, 2026 | RGEN Repligen Corp | Sold | $977K |
| Aug 20, 2026 | RGEN Repligen Corp | Bought (not open market) | $769K |
| Aug 20, 2026 | RGEN Repligen Corp | Bought (not open market) | — |
| Apr 21, 2026 | RGEN Repligen Corp | Sold | $536K |
| Mar 5, 2026 | RGEN Repligen Corp | Bought (not open market) | — |
| Mar 5, 2026 | RGEN Repligen Corp | Bought (not open market) | — |
| Mar 2, 2026 | RGEN Repligen Corp | Sold (not open market) | $201K |
| Feb 27, 2026 | RGEN Repligen Corp | Sold (not open market) | $44.3K |
| Nov 25, 2025 | RGEN Repligen Corp | Sold | $1.2M |
Companies traded
- RGEN Repligen Corp: 9 sales, last Oct 5, 2026